DCGO vs. SHCR, QSI, PIII, TALK, ORGN, INNV, WGS, LTCH, PNTG, and NBTX
Should you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Sharecare (SHCR), Quantum-Si (QSI), P3 Health Partners (PIII), Talkspace (TALK), Origin Materials (ORGN), InnovAge (INNV), GeneDx (WGS), Latch (LTCH), The Pennant Group (PNTG), and Nanobiotix (NBTX).
Sharecare (NASDAQ:SHCR) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk.
DocGo has higher revenue and earnings than Sharecare. Sharecare is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.
35.1% of Sharecare shares are held by institutional investors. Comparatively, 56.4% of DocGo shares are held by institutional investors. 29.3% of Sharecare shares are held by company insiders. Comparatively, 13.8% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Sharecare presently has a consensus price target of $1.00, indicating a potential upside of 16.85%. DocGo has a consensus price target of $7.75, indicating a potential upside of 151.62%. Given Sharecare's stronger consensus rating and higher possible upside, analysts clearly believe DocGo is more favorable than Sharecare.
In the previous week, DocGo had 7 more articles in the media than Sharecare. MarketBeat recorded 19 mentions for DocGo and 12 mentions for Sharecare. Sharecare's average media sentiment score of 0.59 beat DocGo's score of -0.04 indicating that DocGo is being referred to more favorably in the news media.
Sharecare has a beta of 0.26, suggesting that its share price is 74% less volatile than the S&P 500. Comparatively, DocGo has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.
DocGo received 35 more outperform votes than Sharecare when rated by MarketBeat users. Likewise, 73.21% of users gave DocGo an outperform vote while only 35.29% of users gave Sharecare an outperform vote.
DocGo has a net margin of 2.98% compared to DocGo's net margin of -30.71%. Sharecare's return on equity of 6.20% beat DocGo's return on equity.
Summary
DocGo beats Sharecare on 16 of the 18 factors compared between the two stocks.
Get DocGo News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
